Biomarkers in translation; past, present and future

Toxicology

Volumn 245, Issue 3, 2008, Pages 163-166

  Lock, Edward A ^a   Bonventre, Joseph V ^b  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Acute kidney injury; Biomarker

Indexed keywords

4 AMINOHIPPURIC ACID; ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BETA 2 MICROGLOBULIN; BILIRUBIN; BIOLOGICAL MARKER; CREATINE KINASE; CREATININE; CYSTATIN C; GLUCOSE; INTERLEUKIN 18; INULIN; LACTATE DEHYDROGENASE; N ACETYL BETA GLUCOSAMINIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; RETINOL BINDING PROTEIN; TROPONIN I; TROPONIN T; UREA;

ARTICLE; CARDIOTOXICITY; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; HEART INJURY; HUMAN; KIDNEY INJURY; LIVER TOXICITY; NEPHROTOXICITY; NONHUMAN; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; TISSUE INJURY; TOXICITY TESTING; URINALYSIS;

ANIMALS; BIOLOGICAL MARKERS; CLINICAL TRIALS AS TOPIC; DRUG EVALUATION, PRECLINICAL; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PESTICIDES; TOXICOLOGY;

ANIMALIA;

EID: 39749194887     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2007.12.004     Document Type: Article

References (13)

1. Berliner R.W. Remembering Homer Smith. Kidney Int. 43 (1993) 171-172
2. Berson S.A., and Yalow R.S. Assay of plasma insulin in human subjects by immunological methods. Nature 184 (1959) 1648-1649
3. Biomarkers definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69 (2001) 89-95
4. Cameron J.S. The discovery of diabetic nephropathy: from small print to centre stage. J. Nephrol. Suppl. 10 (2006) S75-S87
5. Chertow G.M., Burdick E., Honour M., Bonventre J.V., and Bates D.W. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J. Am. Soc. Nephrol. 16 (2005) 3365-3370
6. Dolci A., and Panteghini M. The exciting story of cardiac biomarkers: from retrospective detection to gold diagnostic standard for acute myocardial infarction and more. Clin. Chim. Acta 369 (2006) 179-187
7. Eknoyan G., and Nagy J. A history of diabetes mellitus or how a disease of the kidneys evolved into a kidney disease. Adv. Chronic Kidney Dis. 12 (2005) 223-229
8. Kohler G., and Milstein C. Continuous cultures of fused cells secreting antibodies of predefined specificity. Nature 256 (1975) 495-497
9. Ladenson J.H. A personal history of markers of myocyte injury [myocardial infarction]. Clin. Chim. Acta 381 (2007) 3-8
10. Lassnigg A., Schmidlin D., Mouhieddine M., Bachmann L.M., Druml W., Bauer P., and Hiesmayr M. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J. Am. Soc. Nephrol. 15 (2004) 1597-1605
11. Rosalki S.B., Roberts R., Katus H.A., Giannitsis E., and Ladenson J.H. Cardiac biomarkers for detection of myocardial infarction: perspectives from past to present. Clin. Chem. 50 (2004) 2205-2213
12. Sharratt M., and Frazer A.C. The sensitivity of function tests in detecting renal damage in the rat. Toxicol. Appl. Pharmacol. 5 (1963) 36-48
13. Zheng G., Patolsky F., Cui Y., Wang W.U., and Lieber C.M. Multiplexed electrical detection of cancer markers with nanowire sensor arrays. Nat. Biotechnol. 23 (2005) 1294-1301